Edition:
United Kingdom

Kala Pharmaceuticals Inc (KALA.OQ)

KALA.OQ on NASDAQ Stock Exchange Global Select Market

15.16USD
23 May 2018
Change (% chg)

$0.37 (+2.50%)
Prev Close
$14.79
Open
$14.79
Day's High
$15.41
Day's Low
$14.79
Volume
33,745
Avg. Vol
69,676
52-wk High
$26.74
52-wk Low
$11.81

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.51 December 26 May 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 1 1 1 1
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.25 1.25 1.25 1.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 3 0.00 0.00 0.00 --
Quarter Ending Sep-18 3 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 --
Year Ending Dec-19 4 19.85 25.00 14.00 --
Earnings (per share)
Quarter Ending Jun-18 3 -0.51 -0.47 -0.55 --
Quarter Ending Sep-18 3 -0.53 -0.49 -0.59 --
Year Ending Dec-18 3 -2.07 -1.95 -2.25 --
Year Ending Dec-19 4 -2.84 -1.99 -3.38 --
LT Growth Rate (%) 1 -92.40 -92.40 -92.40 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.00 0.00 0.00 0.00
Quarter Ending Dec-17 0.00 0.00 0.00 0.00
Quarter Ending Sep-17 9.30 0.00 9.30 100.00
Quarter Ending Jun-17 3.10 0.00 3.10 100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 0.00 0.00 0.00 0.00 --
Quarter Ending Sep-18 0.00 0.00 0.00 0.00 --
Year Ending Dec-18 0.00 0.00 0.00 0.00 --
Year Ending Dec-19 19.85 19.85 27.17 35.00 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 2
Earnings